XML 40 R26.htm IDEA: XBRL DOCUMENT v3.25.4
Fair Value Measurements
12 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements

Note 17 — Fair Value Measurements

 

The carrying amounts of the Company’s cash, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company believes the aggregate carrying value of debt approximates its fair value as of September 30, 2025 and 2024 due to the relatively short duration of the notes payable, the 7% promissory notes - related parties and the notes payable - related parties.

 

Fair Value Hierarchy

 

Liabilities measured at fair value on a recurring basis as of September 30, 2025 are as follows:

 

   Level 1   Level 2   Level 3   Total 
                 
Earnout liability  $   $   $1,240   $1,240 
Liability-classified warrants           6,859    6,859 
Total  $   $   $8,099   $8,099 

 

The Company classifies the earnout liability, the PIPE make-whole liability and the liability-classified warrants and the SAFEs as Level 3 financial instruments due to the judgment required to develop the assumptions used and the significance of those assumptions to the fair value measurement. No financial instruments were transferred between levels of the fair value hierarchy during the years ended September 30, 2025 or 2024.

 

 

MOBIX LABS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(in thousands, except share and per share amounts)

 

The following table provides a reconciliation of the balance of financial instruments measured at fair value on a recurring basis using Level 3 inputs:

 

   Earnout
Liability
   Liability Classified
Warrants
   PIPE
Make-Whole
Liability
   SAFEs 
Balance, September 30, 2023  $   $   $   $1,512 
Liabilities recognized in the Merger   33,559    150    2,071     
Sale of warrants in the July 2024 Private Placement       6,397         
Other warrants issued       732         
Conversion to Class A Common Stock in the Merger               (1,522)
Exercise of warrants       (3,393)         
Settlement of liability       (332)   (1,241)    
Change in fair value included in net loss   (31,879)   (1,415)   (830)   10 
Balance, September 30, 2024  $1,680   $2,139   $   $ 
Sale of warrants in the April 2025 Offering       2,853    -    - 
Issuance of inducement warrants       5,699    -    - 
Modification of warrants       1,214    -    - 
Exercise of warrants       (4,242)   -    - 
Change in fair value included in net loss   (440)   (804)   -    - 
Balance, September 30, 2025  $1,240   $6,859    -    - 

 

Liability-Classified Warrants

 

The Company estimates the fair value of liability classified warrants, other than the Private Warrants, using the Black-Scholes option pricing model, as described above under Note 2 — Summary of Significant Accounting Policies—Stock-Based Compensation. The following table summarizes the assumptions used in estimating the fair value of liability-classified warrants at the respective dates:

 

   September 30, 
   2025   2024 
         
Stock price  $0.81   $1.06 
Expected volatility   79.0%   55.7%
Risk-free rate   3.7%   3.53.9%
Contractual term   4.34.9 years    1.15.1 years 

 

The Company estimates the fair value of the Private Warrants based on quoted market prices for the Public Warrants, which have substantially the same economic characteristics.

 

 

MOBIX LABS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)

(in thousands, except share and per share amounts)

 

Earnout Liability

 

The Company estimates the fair value of the earnout liability using a Monte Carlo simulation model that utilizes assumptions, including volatility, expected term and risk-free rate that determine the probability of achieving the earnout conditions. The following table summarizes the assumptions used in estimating the fair value of the earnout liability at the respective dates:

 

   September 30, 
   2025   2024 
         
Stock price  $0.81   $1.06 
Expected volatility   80%   70%
Risk-free rate   3.8%   3.6%
Contractual term   6.2 years    7.2 years